Literature DB >> 31707467

Measurement of mucociliary clearance in the patients with multiple sclerosis.

Ender Sahin1, Mehmet Hamamcı2, Yunus Kantekin3.   

Abstract

OBJECTIVES: The aim of the present study was to measure nasal mucociliary clearance (NMC) time in the patients with MS and to compare the findings with healthy population.
METHODS: Totally 97 individuals including 47 patients with relapsing-remitting multiple sclerosis and 50 healthy volunteers were enrolled into the study. Saccharin clearance test was performed on both groups and NMC time was measured. Data analysis was performed by SPSS version 24.0 statistics program (SPSS Inc., Chicago, Illinois, USA). Statistical tests were interpreted at p < 0.05 significance level.
RESULTS: The NMC time averages in MS patients and healthy control group were 12.43 ± 4.05 min and 8.14 ± 2.87 min, respectively; the difference between the groups was significant (p < 0.001). There was a statistically strong association between NMC time values and Expanded Disability Status Scale (EDSS) values in MS patients (r = 0.817, p < 0.001).
CONCLUSION: We found nasal mucociliary transport time longer in MS patients than healthy population in the present study. To the best of our knowledge, there is not any study conducted about this topic in the literature. We believe that our findings would shed a light on further studies.

Entities:  

Keywords:  Disability; Infection; Mucociliary clearance; Nasal

Mesh:

Year:  2019        PMID: 31707467     DOI: 10.1007/s00405-019-05717-w

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  25 in total

1.  The role of rhinoscintigraphy in the evaluation of nasal mucociliary clearance function in patients with sinusitis.

Authors:  S S Sun; J F Hsieh; S C Tsai; Y J Ho; C H Kao
Journal:  Nucl Med Commun       Date:  2000-11       Impact factor: 1.690

2.  The risk of relapses in multiple sclerosis during systemic infections.

Authors:  Jorge Correale; Marcela Fiol; Wendy Gilmore
Journal:  Neurology       Date:  2006-07-26       Impact factor: 9.910

3.  Investigating nasal cytology as a potential tool for diagnosing occupational rhinitis in woodworkers.

Authors:  Claudia Staffieri; Andrea Lovato; Federica Aielli; Martina Bortoletto; Luciano Giacomelli; Mariella Carrieri; Salvatore Romeo; Paolo Boscolo-Rizzo; Maria Cristina Da Mosto; Giovanni Battista Bartolucci; Gino Marioni; Maria Luisa Scapellato
Journal:  Int Forum Allergy Rhinol       Date:  2015-06-05       Impact factor: 3.858

Review 4.  Cilia dysfunction.

Authors:  David A Gudis; Noam A Cohen
Journal:  Otolaryngol Clin North Am       Date:  2010-06       Impact factor: 3.346

Review 5.  Multiple sclerosis.

Authors:  Alan J Thompson; Sergio E Baranzini; Jeroen Geurts; Bernhard Hemmer; Olga Ciccarelli
Journal:  Lancet       Date:  2018-03-23       Impact factor: 79.321

6.  Frequency of superantigen encoding genes of Staphylococcus aureus isolates collected from multiple sclerosis (MS) patients and nasal carriers.

Authors:  Javid Sadeghi; Naser Alizadeh; Mahin Ahangar Oskouei; Delara Laghusi; Daryush Savadi Oskouei; Masoud Nikanfar; Mir Naser Seyyed Mousavi
Journal:  Microb Pathog       Date:  2018-12-13       Impact factor: 3.738

Review 7.  The role of infections in multiple sclerosis.

Authors:  Mariano Marrodan; Lucas Alessandro; Mauricio F Farez; Jorge Correale
Journal:  Mult Scler       Date:  2019-01-14       Impact factor: 6.312

8.  Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study.

Authors:  O Andersen; P E Lygner; T Bergström; M Andersson; A Vahlne
Journal:  J Neurol       Date:  1993-07       Impact factor: 4.849

9.  Woodworkers and the inflammatory effects of softwood/hardwood dust: evidence from nasal cytology.

Authors:  Andrea Lovato; Claudia Staffieri; Giancarlo Ottaviano; Rocco Cappellesso; Luciano Giacomelli; Giovanni Battista Bartolucci; Maria Luisa Scapellato; Gino Marioni
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-21       Impact factor: 2.503

Review 10.  Multiple sclerosis treatment and infectious issues: update 2013.

Authors:  A Winkelmann; M Loebermann; E C Reisinger; U K Zettl
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.